Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 28, 2006; 12(20): 3196-3203
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3196
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3196
Update on obesity surgery
Dan Eisenberg, Andrew J Duffy, Robert L Bell, Department of Surgery, Yale University School of Medicine, 40 Temple St. Suite 3A New Haven, CT 06510, United States
Author contributions: All authors contributed equally to the work.
Correspondence to: Robert L Bell, MD, Director of Bariatric Surgery, Department of Surgery, Yale University School of Medicine, 40 Temple St. Suite 3A, New Haven, CT 06510, United States. robert.bell@yale.edu
Telephone: +1-203-7649060 Fax: +1-203-7649066
Received: March 29, 2006
Revised: April 7, 2006
Accepted: April 16, 2006
Published online: May 28, 2006
Revised: April 7, 2006
Accepted: April 16, 2006
Published online: May 28, 2006
Abstract
The prevalence of obesity in the United States has reached epidemic proportions. With more than 30 million Americans clinically obese, the younger population has also been affected. Surgical therapy should be offered to the severely obese patient who is refractory to nonsurgical therapy, as established by the 1991 NIH Consensus Conference on Gastrointestinal Surgery for Severe Obesity. Surgery is currently the most effective therapy for weight loss. It is far more effective than any other treatment modality, both in terms of the amount of weight loss and in terms of durability in maintaining weight loss.
Keywords: Obesity, Gastrointestinal surgery, Roux-Y gastric bypass